Why Investigators Hold The Cards To Clinical Trial Success

Contributed By Dr. Claire Sears, Investigator Engagement, DrugDev

Including experienced investigators early in the process of writing a protocol would help prevent common issues that hinder trial enrollment and retention” said a clinical trial investigator from Jacksonville, Fla.

Clinical trials demand the active participation of investigators. It’s that simple. And that complicated.

The doctor-investigators who commit their time and expertise to upholding the integrity of a clinical trial need our help and encouragement. We already know they value the opportunity to be involved at the cutting edge of exciting drug development and to provide new treatment options for their patients. But the current marketplace climate is doing anything but inspiring their participation.